SEARCH IN BRIEF

 
Dempsey joins Nightingale

Leading science architect, Paul Dempsey, is to join Nightingale Associates as the new board-level Science Development Director this month.

Specialising in the pharmaceutical and science sector, Dempsey previously worked for CBRE, Pfizer and Bovis Lend Lease Pharmaceutical. His addition to Nightingale Associates, a leading architectural practice specialising in health, education and science buildings, aims to build upon the practice’s accomplishments within the science sector, helping to promote the company’s knowledge and innovation.

Dempsey said: “I am delighted to be joining Nightingale Associates to help further expand the excellent track record it already has in the science sector. My appointment is intended to boost the science capability with our existing clients and to help develop future work in new and exciting industry sectors.”

Dempsey was recognised as a pioneer and leader of ‘Lab of the Future’ projects, was awarded the prestigious William E Upjohn prize for innovation, and was the first non-scientist award winner in Pfizer’s history for his influential role on the Pfizer FlexiLab projects.

Starting in mid-September Dempsey will be based in Nightingale Associates’ London office.

IN BRIEF
Wednesday 16 September 2009
RIBA to open Chapter in India next year
Thu 18 Dec 2014
Download your copy of the Architects and the Media Report
Thu 18 Dec 2014
Kingspan Insulated Panels announces ZerO Energy Lighting Solution and associated report
Wed 17 Dec 2014
ARCKIT picks up multiple accolades at London Design Awards 2014
Tue 16 Dec 2014
Shortlist announced for 'Olympicopolis' in London
Tue 16 Dec 2014
Moshe Safdie to receive 2015 AIA Gold Medal
Thu 11 Dec 2014
Mayor of London approves Wood Wharf
Thu 11 Dec 2014
LAFD called to massive fire at Geoffrey Palmer's Da Vinci complex in Downtown LA
Wed 10 Dec 2014